A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy Participants

NCT04208061 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Dabigatran Etexilate
DRUG: DRV/COBI
DRUG: Ritonavir
DRUG: Darunavir

Sponsor

Janssen Research & Development, LLC